Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


21.08.2017

1 BMC Gastroenterol
1 Gut
1 Hepatology
1 J Clin Gastroenterol
4 J Hepatol
1 J Immunol
1 J Med Virol
1 J Viral Hepat
1 J Virol
4 Lancet Gastroenterol Hepatol
2 PLoS One
1 Transplantation
1 Vaccine
1 Virology (Auckl)


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Gastroenterol

  1. LIN MS, Chen TH, Lin WY, Liu CH, et al
    Add-on neurological benefits of antiviral therapy in HCV patients with chronic kidney disease - a nationwide cohort study.
    BMC Gastroenterol. 2017;17:99.
    PubMed     Text format     Abstract available


    Gut

  2. ZHANG W, Sun M, Chen G, An Y, et al
    Reassessment of gamma-glutamyl transpeptidase to platelet ratio (GPR): a large-sample, dynamic study based on liver biopsy in a Chinese population with chronic hepatitis B virus (HBV) infection.
    Gut. 2017 Aug 16. pii: gutjnl-2017-313896. doi: 10.1136/gutjnl-2017-313896.
    PubMed     Text format    


    Hepatology

  3. HALGAND B, Desterke C, Riviere L, Fallot G, et al
    Hepatitis B virus pregenomic RNA in hepatocellular carcinoma: A nosological and prognostic determinant.
    Hepatology. 2017 Aug 12. doi: 10.1002/hep.29463.
    PubMed     Text format     Abstract available


    J Clin Gastroenterol

  4. LI J, Chang MS, Tran TT, Nguyen MH, et al
    Management of Chronic Hepatitis B in Pregnancy.
    J Clin Gastroenterol. 2017 Aug 14. doi: 10.1097/MCG.0000000000000908.
    PubMed     Text format     Abstract available


    J Hepatol

  5. DONG YANG J, Leise MD
    Reply to " Interferon-free therapy of hepatitis C during wait list and post transplant risk of hepatocellular carcinoma recurrence".
    J Hepatol. 2017 Aug 8. pii: S0168-8278(17)32201.
    PubMed     Text format    

  6. WAZIRY R, Hajarizadeh B, Grebely J, Amin J, et al
    Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression.
    J Hepatol. 2017 Aug 9. pii: S0168-8278(17)32199.
    PubMed     Text format     Abstract available

  7. MELE D, Mantovani S, Oliviero B, Grossi G, et al
    Monocytes inhibit hepatitis C virus-induced TRAIL expression on CD56bright NK cells.
    J Hepatol. 2017 Aug 10. pii: S0168-8278(17)32203.
    PubMed     Text format     Abstract available

  8. DONATO MF, Invernizzi F, Rossi G, Iavarone M, et al
    Interferon-free therapy of hepatitis C during wait list and post-transplant risk of hepatocellular carcinoma recurrence.
    J Hepatol. 2017 Aug 10. pii: S0168-8278(17)32200.
    PubMed     Text format    


    J Immunol

  9. HUANG WC, Easom NJ, Tang XZ, Gill US, et al
    T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance System.
    J Immunol. 2017;198:1172-1182.
    PubMed     Text format     Abstract available


    J Med Virol

  10. ZHAO C, Geng Y, Huang W, Ma H, et al
    Valuable Antibody Detection Method for Classifying Hepatitis E Virus Genotypes.
    J Med Virol. 2017 Aug 17. doi: 10.1002/jmv.24915.
    PubMed     Text format     Abstract available


    J Viral Hepat

  11. KRAMER JR, El-Serag HB, Taylor TJ, White DL, et al
    Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.
    J Viral Hepat. 2017 Aug 16. doi: 10.1111/jvh.12728.
    PubMed     Text format     Abstract available


    J Virol

  12. KAUSHIK N, Subramani C, Anang S, Muthumohan R, et al
    Zinc salts block Hepatitis E virus replication by inhibiting the activity of viral RNA-dependent RNA polymerase.
    J Virol. 2017 Aug 16. pii: JVI.00754-17. doi: 10.1128/JVI.00754.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  13. LAWITZ E, Buti M, Vierling JM, Almasio PL, et al
    Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST
    Lancet Gastroenterol Hepatol. 2017 Aug 9. pii: S2468-1253(17)30163.
    PubMed     Text format     Abstract available

  14. EMMANUEL B, Wilson EM, O'Brien TR, Kottilil S, et al
    Shortening the duration of therapy for chronic hepatitis C infection.
    Lancet Gastroenterol Hepatol. 2017 Aug 9. pii: S2468-1253(17)30053.
    PubMed     Text format     Abstract available

  15. GANE EJ, Pianko S, Roberts SK, Thompson AJ, et al
    Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-C
    Lancet Gastroenterol Hepatol. 2017 Aug 9. pii: S2468-1253(17)30159.
    PubMed     Text format     Abstract available

  16. LAU G
    Shortening HCV therapy: science meets public health.
    Lancet Gastroenterol Hepatol. 2017 Aug 9. pii: S2468-1253(17)30215.
    PubMed     Text format    


    PLoS One

  17. LIU X, He L, Han J, Wang L, et al
    Association of neutrophil-lymphocyte ratio and T lymphocytes with the pathogenesis and progression of HBV-associated primary liver cancer.
    PLoS One. 2017;12:e0170605.
    PubMed     Text format     Abstract available

  18. CHO YE, Im EJ, Moon PG, Mezey E, et al
    Increased liver-specific proteins in circulating extracellular vesicles as potential biomarkers for drug- and alcohol-induced liver injury.
    PLoS One. 2017;12:e0172463.
    PubMed     Text format     Abstract available


    Transplantation

  19. VINAIXA C, Strasser SI, Berenguer M
    DISEASE REVERSIBILITY IN PATIENTS WITH POSTHEPATITIS C CIRRHOSIS: IS THE POINT OF NO RETURN THE SAME BEFORE AND AFTER LIVER TRANSPLANTATION? A REVIEW.
    Transplantation. 2017 Jan 6. doi: 10.1097/TP.0000000000001633.
    PubMed     Text format     Abstract available


    Vaccine

  20. CAO YF, Tao H, Hu YM, Shi CB, et al
    A phase 1 randomized open-label clinical study to evaluate the safety and tolerability of a novel recombinant hepatitis E vaccine.
    Vaccine. 2017 Aug 10. pii: S0264-410X(17)30731.
    PubMed     Text format     Abstract available


    Virology (Auckl)

  21. NASIR IA, Yakubu S, Mustapha JO
    Epidemiology and Synergistic Hepatopathology of Malaria and Hepatitis C Virus Coinfection.
    Virology (Auckl). 2017;8:1178122X17724411.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: